Cancer Immunotherapy Deal Mania Continues
Friday, April 3, 2015 - 11:40
in Health & Medicine
Pharmaceuticals: Novartis and Merck Serono broaden their immuno-oncology portfolios
Pharmaceuticals: Novartis and Merck Serono broaden their immuno-oncology portfolios